Steven D. Ertel
2014
In 2014, Steven D. Ertel earned a total compensation of $454.8K as Executive Vice President and Chief Operating Officer at Acceleron Pharma, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $117,250 |
|---|---|
| Salary | $335,000 |
| Other | $2,500 |
| Total | $454,750 |
Ertel received $335K in salary, accounting for 74% of the total pay in 2014.
Ertel also received $117.3K in non-equity incentive plan and $2.5K in other compensation.
Rankings
In 2014, Steven D. Ertel's compensation ranked 10,588th out of 13,032 executives tracked by ExecPay. In other words, Ertel earned more than 18.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,588 out of 13,032 | 19th |
Division Manufacturing | 4,032 out of 4,966 | 19th |
Major group Chemicals And Allied Products | 1,386 out of 1,686 | 18th |
Industry group Drugs | 1,110 out of 1,365 | 19th |
Industry Biological Products, Except Diagnostic Substances | 199 out of 236 | 16th |
Source: SEC filing on April 15, 2016.
Ertel's colleagues
We found four more compensation records of executives who worked with Steven D. Ertel at Acceleron Pharma in 2014.